Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from PainChek Ltd ( (AU:PCK) ) is now available.
PainChek Ltd announced an upcoming investor webinar to discuss their quarterly update and Appendix 4C, highlighting the company’s ongoing efforts to engage with stakeholders and provide transparency about their operations. The announcement underscores PainChek’s commitment to maintaining its position as a leader in pain assessment technology, with implications for expanding their market presence and enhancing stakeholder relations.
More about PainChek Ltd
PainChek Ltd is a company operating in the healthcare technology industry, known for developing the world’s first smart device-based pain assessment and monitoring application. Their primary product, the PainChek app, is a regulatory-cleared medical device designed to assess pain in individuals who cannot reliably self-report their pain. The app is available globally and is used in over 1,900 aged care facilities, with more than 14 million digital pain assessments conducted. PainChek’s technology is trusted by healthcare professionals and has been validated through clinical studies.
Average Trading Volume: 5,008,039
Technical Sentiment Signal: Buy
Current Market Cap: A$102.3M
See more data about PCK stock on TipRanks’ Stock Analysis page.